HIV Rapid Testing Market (2023 - 2030)_Sample Extract.pdf.pdf

HIV Rapid Testing Market size is estimated to reach $15.07 billion by 2030, growing at a CAGR of 7.22% during the forecast period 2024-2030.

1. Copyright ©2024 IndustryARC
Page - 1
Web - www.industryarc.com|Mail – sales@indust
HIV RAPID TESTING MARKET

2. Copyright ©2024 IndustryARC
| |[email protected] |
OUR EXPERTISE - END TO END CONSULTING
[phone] Buy Now
Inquiry Before Buying
Choosing theC hRoigohsti nCgo tnhseu Rltinggh tP Caortnnseurl tiisn Cg hPoaorstninegr itsh e
Energy and Power Life sciences and Healthcare IT & Consulting
Electronics Chemicals and Materials Consumer & Retail

3. Copyright ©2024 IndustryARC
| |
- 004
- 006
- 009
- 018
- 027
- 031
- 035
- 042
- 047
- 054
- 064
- 069
- 074
- 082
- 087
- 123
- 125
[email protected] | [phone] Buy Now
Inquiry Before Buying
Chapter 01: HIV Rapid Testing Market Overview
Chapter 01: HIV Rapid Testing Market Overview
Chapter 02: HIV Rapid Testing Market Executive Summary
Chapter 02: HIV Rapid Testing Market Executive Summary
Chapter 03: HIV Rapid Testing Market Comparative Analysis
Chapter 03: HIV Rapid Testing Market Comparative Analysis
Chapter 04: HIV Rapid Testing Market Forces
Chapter 04: HIV Rapid Testing Market Forces
Chapter 05: HIV Rapid Testing Market Strategic Analysis
Chapter 05: HIV Rapid Testing Market Strategic Analysis
Chapter 06: HIV Rapid Testing Market - By HIV Type
Chapter 07: HIV Rapid Testing Market - By Sample Type
Chapter 07: HIV Rapid Testing Market - By Sample Type
Chapter 08: HIV Rapid Testing Market - By Test Type
Chapter 09: HIV Rapid Testing Market - By Technology
Chapter 10: HIV Rapid Testing Market - By Demographics
Chapter 11: HIV Rapid Testing Market - By Test Generation
Chapter 12: HIV Rapid Testing Market - By Application
Chapter 12: HIV Rapid Testing Market - By Application
Chapter 13: HIV Rapid Testing Market - By End User
Chapter 13: HIV Rapid Testing Market - By End User
Chapter 14: HIV Rapid Testing Market - By Distribution Channel
Chapter 15: HIV Rapid Testing Market - By Geography
Chapter 15: HIV Rapid Testing Market - By Geography
Chapter 16: HIV Rapid Testing Market Entropy
Chapter 17: HIV Rapid Testing Market company Profiles
Chapter 17: HIV Rapid Testing Market company Profiles
Topics Slide No

4. Copyright ©2024 IndustryARC
| |[email protected] | [phone] Buy Now
Inquiry Before Buying
HIV RAPID TESTING MARKET OVERVIEW
CHAPTER - 01

5. Copyright ©2024 IndustryARC ❖
| |[email protected] | [phone] Buy Now
Inquiry Before Buying
Market Definition
❖
HIV rapid testing is a Human
Immunodeficiency Virus (HIV) diagnostic
test that provides results fast, generally
within minutes. Rapid HIV tests identify the
presence of HIV antibodies or antigens in
the body using a tiny sample of blood or
oral fluid.
The rising incidence of HIV infections
worldwide is a significant factor driving the
growth of the HIV Rapid Testing market.
Governments all across the globe are
investing in HIV prevention, testing, and
treatment programmes, fueling demand
for HIV rapid testing.
❖
❖
Scope
❖
The current scope covers the market for
HIV Rapid Testing.
The market is segment By HIV Type, By
❖
Sample Type, By Test Types, By
Technology, By Demographics, By Test
Generation, By Application, By Distribution
Channel and by geography.
HIV Rapid Testing Market:
❖
The development of innovative products
is one of the key trends in the market for
HIV fast testing. The lateral flow method
that has historically been used in rapid
HIV testing is rapidly being replaced by
more sophisticated technologies like
ELISA and PCR. These more recent tests
are more accessible to both people and
healthcare professionals since they have
higher sensitivity and specificity and are
simpler to use.
Growing demand for at-home HIV
testing kits is another industry trend.
People are looking for more practical
and accessible solutions as they become
more aware of the significance of HIV
testing. Without going an appointment
❖
with a healthcare practitioner, home-
based testing kits offer a quick and
discrete option for people to test
themselves for HIV.
HIV Rapid Testing Market
Revenue, 2022-2030 ($M)
HIV Rapid Testing Market is driven by the
below-mentioned factors:
❖
❖
Increasing prevalence of HIV
Ease of use and fast results
Development of innovative HIV
rapid testing technologies
❖
❖
Government initiatives
Source: IndustryARC Analysis, Expert Insights
1,600.00
1,400.00
1,200.00
1,000.00
800.00
600.00
400.00
200.00
-
Revenue ($M)

6. Copyright ©2024 IndustryARC
| |[email protected] | [phone] Buy Now
Inquiry Before Buying
HIV RAPID TESTING MARKET EXECUTIVE SUMMARY
CHAPTER - 02

7. Copyright ©2024 IndustryARC
|
The increasing prevalence of HIV/AIDS worldwide and the demand for early
identification and treatment have been driving the market for HIV antibody
rapid testing. According to
Centers for Disease Control and Prevention (CDC), Antibody testing are the
fastest tests and the only HIV self-test approved by the US Food and Drug
Administration (FDA).
HIV antigen/antibody combination test kits are becoming more widely available
on the market as a result of the rising demand for HIV self-testing kits.
[email protected]| [phone] | Buy Now
MAJOR TRENDS/INSIGHTS
❖
Inquiry Before Buying
❖
❖
The HIV epidemic continues to pose a
serious threat to public health. As HIV
incidence rises, there is an increasing
demand for rapid and reliable
diagnostic methods such antigen
rapid testing.
According
Programme
to United Nations
AIDS
(UNAIDS) report, In 2021, there were
on HIV and
38.4
million]
worldwide
million [33.9 million-43.8
individuals
HIV-positive
and 650000 [510000-
860000] persons passed away from
AIDS-related diseases. Increased HIV
testing, prevention, and treatment
programmes are being implemented
by governments all around the world.
The demand for
HIV testing kits, including the antigen/antibody combination test,
has increased as a result.
CAGR By Test Type, 2023-2030, (%) Market Share, By Test Type, 2022(%)
❖
❖
❖
Antigen/ Antibody
Combination Test
Antigen Rapid Test
Antibody Rapid Test
0.0 0% 5.00%
Source: IndustryARC Analysis, Expert Insights
10.00%
Antibody
Rapid Test
Antigen/
Antibody
Combination
Test
Antigen Rapid
Test

8. Copyright ©2024 IndustryARC
| |[email protected] | [phone]
Governments in North America have been increasing public health
efforts to increase HIV testing awareness and promote the use of rapid
testing. As a result, the number of testing facilities and clinics offering
rapid testing services has increased. For instance, The National HIV/AIDS
Strategy (the Strategy), the country's third, updates the HIV National
Strategic Plan (2021). The Plan has ambitious goals for ending the HIV
pandemic in the United States by 2030, including a 75% decrease in new
HIV infections by 2025 and a 90% reduction by 2030.
Buy Now
MAJOR TRENDS/INSIGHTS
❖
Inquiry Before Buying
❖
❖
❖
CAGR By Geography, 2023-2030, % Market Share, By Geography,
2022(%)
Governments in several nations of APAC region
are investing in HIV testing programs to stop the
spread of the infection. As a result, more
individuals are being tested, which is fueling the
demand for HIV Rapid Testing Market For
instance, In March 2022, The National AIDS and
STD Prevention Programme, a Central Sector
Scheme wholly supported by the Government of
India, would continue under the Union Cabinet's
approval of phase-V of the Program from 1 April
2021 to 31 March 2026, with an expenditure of
US$ 1881.64 Million. According to the World
Health Organization (WHO), nearly 1,07,000
persons were diagnosed with HIV in the
European Region by 2022, with around 17,000
being diagnosed in the EU/EEA. Owing to an
increase in HIV prevalence in many regions,
there is a rising demand for rapid testing for HIV
using rapid testing technologies. According to
World Health Organization (WHO), In 2021, 1.5
million [1.1-2.0 million] people
diagnosed HIV, and 6,50,000 [5,10,000-
8,60,000] people died from HIV-related causes.
❖
❖
APAC
0.00% 2.00% 4.00% 6.00% 8.00%10.00%
Middle East & Africa
Europe
South America
North America
Source: IndustryARC Analysis, Expert Insights
North America
South America
Europe
APAC
Middle East &
Africa

9. Copyright ©2024 IndustryARC
| |[email protected] | [phone] Buy Now
Inquiry Before Buying
HIV RAPID TESTING MARKET FORCES
CHAPTER - 04

10. Copyright ©2024 IndustryARC
|
Projected
Impact on
HIV Rapid
Testing
Market
[email protected] |
Impact
Low
Medium Growth
High Impact
Impact
[phone]
Technological
advancement in
HIV Rapid Testing
Certainty
| Buy Now
Rising HIV
prevention and
treatment
program
Increasing
prevalence of
HIV
High Growth Impact
High
Inquiry Before Buying
Low Impact
Low Growth

11. | |[email protected] | [phone] Buy Now
Inquiry Before Buying
Increasing prevalence of HIV/AIDS is driving the growth of the HIV Rapid Testing market. The factors that increases th
cases of HIV cases are lack of awareness and education, stigma & discrimination, poverty as well as limited access t
healthcare. According to World Health Organization, HIV/AIDS continues to be a major public health issue worldwide
with an estimated 38 million people living with HIV/AIDS globally in 2021. Of the people living with HIV in 2021, 36.
million were adults and 1.7 million were children under age 15. In 2021, 650 000 people approximately died from HIV
related causes and 1.5 million people acquired HIV. As a result, there is a growing demand for HIV rapid testing, whic
allows for quick and easy diagnosis of the disease. Also, According to Kaiser Family Foundation, Global prevalence of HI
among adults (the percent of people ages 15-49 who are infected) has leveled since 2001 and was0.7%in 2021. Sub
Saharan Africa region is home to two-thirds of all people living with HIV globally, is the hardest hit region in the world
followed by Asia and the Pacific. Also, Latin America as well as Eastern Europe and Central Asia are also heavily affecte
with HIV. In India, according to NACO ( National AIDS Control Organization), the northeast region states have the highes
adult HIV prevalence (2.70% in Mizoram, 1.36% in Nagaland and 1.05% in Manipur), followed by southern States (0.67% i
Andhra Pradesh, 0.47% in Telangana and 0.46% in Karnataka). The number of People Living with HIV (PLHIV) are
estimated at around 24 lakhs and the Southern States have the largest nCuompybreigr hot f© P2L0H2IV4 Ivnizd.
MstrayhAaRraCs htra, Andhra
Pradesh and Karnataka being the top three.
Such rising cases of HIV globally accelerates the demand for HIV Rapid Testing.
Increasing prevalence of HIV is projected to fuel market growth:
❖
❖
❖
❖
❖

12. Copyright ©2024 IndustryARC
| |[email protected] | [phone] Buy Now
Inquiry Before Buying
HIV RAPID TESTING MARKET STRATEGIC ANALYSIS
CHAPTER - 05

13. | |[email protected] | [phone] Buy Now
Inquiry Before Buying
Technology Push
Raw Material Suppliers
(40-45%)
Manufacturers
(15-20%)
Sales &
Marketing
(10-15%)
HIV Rapid Testing Market Value Chain Analysis
Distributors
(20-30%)
End Users
(10-15%)
Market Pull
Source: Industry Publications, IndustryARC Analysis
❖
❖
❖
❖
❖
The various stakeholders that have a significant share in the value chain of the Antiscalent Market are raw material suppliers
manufacturers, distributors and End Users. The raw material suppliers holds the major share in the value chain of the HIV Rap
Testing Market as they are responsible to provide the inputs needed to manufacture HIV rapid testing kits which include supplie
of raw materials, equipment, and technology. The next step in the value chain is the manufacturers of HIV Rapid Testing Kit. The
are responsible for process of converting inputs into finished HIV rapid testing kits. This may involve various stages such a
assembly, testing, and packaging. Sales and Marketing are involved with activities involved in promoting and selling HIV rap
testing kits. This may include advertising, promotions, and public relations. The distributors of the HIP Rapid Testing Marke
connect the end user and the
company in a cost effective sales channel partnership. The last step in the value chain is End users. They are responsible for
using HIV rapid testing kits for diagnostic purposes.
Thus, value chain of the HIV Rapid Testing market can help identify areas of potential improvement, cost savings, and value
creation. By identifying such areas, companies can improve their competitiveness and profitability in the market.
Copyright ©2024 IndustryARC

14. The HIV Rapid Testing market was valued at $860.25 million in 2022 and is estimated to generate $924.94 million i
revenue by the end of 2023 and $1507.12 million by 2030. The market is estimated to grow at a CAGR of 7.22% from
2023 to 2030. The Increasing prevalence of HIV/AIDS, development of new and improved rapid testing technologie
along with the increasing HIV prevention and treatment program are driving the growth of the market. The growin
demand of Multiplex HIV Rapid Testing is anticipated to create opportunities for the growth of the HIV
Rapid Testing market during the forecast period.
The market is forecasted to be highly competitive since it is fragmented with presence of several established players.
and the major development strategies are product launches, M&A and partnership among others.
Copyright ©2024 IndustryARC
[email protected]| [phone] | Buy Now |
Inquiry Before Buying
❖
❖
❖
❖
In 2022, the
market was
valued at
$860.25 mn
Estimated to
surpass a
market value
of $924.94 mn
by the end of
2023
HIV Rapid Testing Market Life Cycle Analysis
Estimated to
reach the
sales of
$1507. 12 mn
by 2030
Source: IndustryARC Analysis and Expert Insights

15. Copyright ©2024 IndustryARC
| |[email protected] | [phone] Buy Now
Inquiry Before Buying
HIV RAPID TESTING MARKET - BY SAMPLE TYPE
CHAPTER - 07

16. | |[email protected] | [phone] Buy Now
Inquiry Before Buying
Blood samples include greater amounts of HIV antibodies, these HIV
rapid testing kits uses a drop of blood from the fingertip to detec
antibodies in the blood. Blood sample-based HIV rapid test kits are
widely recommended by medical practitioners owing to its high
concentration of HIV antibodies. HIV rapid tests using a blood sample
are available at many healthcare facilities, including clinics and
hospitals. These tests often provide results in 20-30 minutes, making
them a fast and convenient choice for HIV screening and diagnosis. A
a result, demand for HIV rapid test through blood sample i
increasing. The development of new technologies and products tha
allow both faster and more accurate HIV detection has also been a
major driving force in the HIV rapid test market by blood sample type
For instance, in November 2022, Abbott has announced the
PanbioTM HIV Self Test, a new HIV home test. The PanbioTM HIV Sel
Test is a new rapid fingerstick blood test for the detection of HIV-1
and HIV-2 antibodies, the two forms of HIV virus that can
cause AIDS.
Blood segment of HIV Rapid Testing Market generated a revenue of
$508.1m in 2022 and is projected to reach a revenue of $903.6m by
2030 growing at a CAGR of 7.41% during 2022-2030.
Copyright ©2024 IndustryARC
Blood: HIV Rapid Testing Market
Revenue, 2022-2030 ($M)
Source: IndustryARC Analysis, Expert Insights
❖
❖
❖
❖
❖
1000.00
900.00
800.00
700.00
600.00
500.00
400.00
300.00
200.00
100.00
0.00
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue ($M)

17. [email protected] | [phone]
An HIV rapid test utilizing a serum sample is a diagnostic process fo
identifying the presence of human immunodeficiency virus (HIV
antibodies in a person's bloodstream. The serum includes proteins
and other compounds, such as antibodies produced by the body in
response to HIV infection. Serum samples can be collected easily and
simply, making them an ideal choice for rapid testing. These can be
obtained by a variety of methods, such as blood draws, fingerstick
samples, and saliva samples. Early identification and treatment of HIV
infection can improve health outcomes and lower the risk o
transmission. HIV rapid testing using serum samples enable early
detection and treatment, resulting in growing demand for such tests
For Exmple ,Accu-Tell® HIV 1/2 Rapid Test Cassette (Whole
Blood/Serum/Plasma) is a rapid chromatographic immunoassay fo
the qualitative detection of Human Immunodeficiency Virus (HIV
type 1 and type 2 antibodies in serum or plasma to help in the
diagnosis of HIV infection in 10 minutes. Serum segment of HIV
RapCido pTyersigtihntg © M2a0r2k4e tI ngdeunsetryaAteRdC a
revenue of
$22.2m in 2022 and is projected to reach a revenue of $40.4m by 2030
growing at a CAGR of 7.70% during 2022-2030.
| Buy Now |
Inquiry Before Buying
Serum: HIV Rapid Testing Market
Revenue, 2022-2030 ($M)
45.00
40.00
35.00
30.00
25.00
20.00
15.00
10.00
5.00
0.00
Source: IndustryARC Analysis, Expert Insights
2022 2023 2024 2025 2026 2027 2028 2029 2030
❖
❖
❖
❖
❖
Revenue ($M)

18. | |[email protected] | [phone] Buy Now
Inquiry Before Buying
Urine HIV rapid test is a diagnostic test that identifies HIV antibodies
in urine samples. It is a non-invasive and easy way of HIV testing that
does not require blood samples or needles. The test works by
identifying antibodies that the body's immune system produces in
response to HIV infection. The HIV rapid test using urine is gaining
popularity since it is non- invasive and can be performed without the
assistance of a healthcare practitioner. This sort of test is very
effective in resource-constrained environments and for people who
are afraid to get a blood test. According to the World Health
Organization (WHO), there are 38.4 million individuals living with HIV
by the end of 2021. Due to the high incidence of HIV, there is a strong
demand for effective and easily available diagnostic instruments, such
as HIV rapid urine tests. In general, urine-based HIV fast tests are less
costly than blood-based tests, making them more accessible to low-
income people or resource-limited situations.
Urine segment of HIV RapCido pTyersigtihntg © M2a0r2k4e tI
ngdeunsetrraytAeRdC a revenue of
$46.2m in 2022 and is projected to reach a revenue of $83.3m by
2030 growing at a CAGR of 7.58% during 2022-2030.
Urine: HIV Rapid Testing Market
Revenue, 2022-2030 ($M)
Source: IndustryARC Analysis, Expert Insights
❖
❖
❖
❖
❖
90.00
80.00
70.00
60.00
50.00
40.00
30.00
20.00
10.00
0.00
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue ($M)

19. Copyright ©2024 IndustryARC
| |[email protected] | [phone] Buy Now
Inquiry Before Buying
HIV RAPID TESTING MARKET - BY APPLICATION
CHAPTER - 12

20. [email protected] |
❖
HIV Testing services can be either conventional facility-based or
community based. The facility based testing includes all tests
performed at health facilities either requested by the clients or
healthcare provider-initiated testing and counseling.
Tools and interventions that increase demand for HTS are needed
to reach people who are unaware of HTS options or unwilling to
seek HIV testing service. Some of the following programs which
are listed below are Evidence-based platforms for delivering
demand creation such as peer-led interventions and digital
platforms, such as short pre-recorded videos, Approaches that
show evidence of increased demand such as advertisements of
❖
specific HIV testing attributes and motivational messages could
increase the HIV testing percentage among people where HIV
rapid test kits are used for detection of HIV which leads to growth
of HIV rapid testing market.
According to WHO facts sheet which was published on Jul,2022,
❖
There were 38.4 million people living with HIV at the end of 2021
with 1.5 million people becoming newly infected where the
necessity of HIV rapid testing is huge to avoid spreading where the
demand for HIV rapid testing is expected to grow.
Copyright ©2024 IndustryARC
[phone] | Buy Now |
Inquiry Before Buying
Facility Administered Kit: HIV Rapid
Testing Market Revenue, 2022-2030 ($M)
0
800
Source: IndustryARC Analysis, Expert Insights
1200
1000
600
400
200
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue $M

21. Copyright ©2024 IndustryARC
| |[email protected] | [phone] Buy Now
Inquiry Before Buying
As the HIV testing by the facility based, is performed by the diagnostic experts, the results are more trustworthy and
can be performed in community or at the office, where the facility administered kits are used for detecting HIV which
helps to avoid spreading and consult proper medication to the victim. Due to all these factors the HIV rapid testing
market is expected to have huge demand. Facility Administered Kit segment of HIV Rapid Testing Market generated a
revenue of $644.77 M in 2022 and is projected to reach a revenue of $1081.40 M by 2030 growing at a CAGR of 6.64%
during 2022-2030.
Source: IndustryARC Analysis, Expert Insights
❖
❖

22. Copyright ©2024 IndustryARC
| |[email protected] | [phone] Buy Now
Inquiry Before Buying
HIV RAPID TESTING MARKET - BY END USER
CHAPTER - 13

23. | |[email protected] | [phone] Buy Now
Inquiry Before Buying
Diagnostics Laboratories: HIV Rapid Testing
Market Revenue, 2022-2030, ($M)
13.3.1. Diagnostic Laboratories
❖
The Factors such as the increasing prevalence of HIV along with
growing demand for point-of-care testing for HIV are the
primary reasons for the demand of HIV Rapid Testing in
Diagnostic Laboratories. There has been a growing need of HIV
rapid test among pregnant women as they can avoid the
transfer of the HIV virus to their fetus. The main advantage of
this test is that with early detection, the treatments can begin
early and the individual can take preventive measures sooner.
According to the UNAIDS report 2020, globally, approximately
37.7 million people are living with HIV, of which about 2.3
million infections were recorded in India. Thus, Such factors are
positively impacting the growth of market.
❖
Furthermore, the new research and developments,
technological innovations, and the launch of technologically
advanced products by key players are expected to boost the
growth of the market. The development of IoT-enabled, Real-
Time PCR platform is augmenting the market. In August 2022,
Molbio Diagnostics announced that it has launched Truenat RT-
PCR Test for HIV, a new test for differential diagnosis of HIV 1
and HIV 2 with virCaol lpoyardigsh wt i©th2in0 6204 m Inindu
point-of-care portable, battery-operated, IoT-enabled, Real-
Time PCR platform with a sample-to-result time of less than 1
hour.
700.00
600.00
500.00
400.00
300.00
200.00
100.00
0.00
2022 2023 2024 2025 2026 2027 2028 2029 2030
Market Revenue in $M

24. | |[email protected] | [phone] Buy Now
Inquiry Before Buying
Specialty Clinics: HIV Rapid Testing Market
Revenue, 2022-2030, ($M)
13.3.5 Specialty Clinics
❖
Specialty clinics are healthcare facilities that specialize in
providing medical care for a specific area of health or disease.
These clinics offer specialized services, equipment, and staff who
have extensive training and expertise in the particular field of
healthcare they specialize in.
Specialty clinics use HIV rapid testing as part of their diagnostic
and screening services. In fact, some HIV specialty clinics may rely
on rapid HIV testing as a routine part of their patient care.
Moreover, the most commonly used rapid HIV tests in specialty
clinics are the point-of-care tests, which can provide results in as
little as 20 minutes.
In 2017, FDA approved Fourth Generation Determine HIV-1/2
❖
❖
❖
Ag/Ab Combo Test: This test is a rapid lateral flow
chromatographic immunoassay that detects HIV-1 p24 antigen and
antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma. It
Copyright ©2024 IndustryARC
provides results in about 20 minutes. This test is highly accurate
and can be used to screen for HIV infection in a variety of clinical
settings, including specialty clinics.
120.00
100.00
80.00
60.00
40.00
20.00
0.00
2022 2023 2024 2025 2026 2027 2028 2029 2030
Market Revenue in $M

25. Copyright ©2024 IndustryARC
| |[email protected] | [phone] Buy Now
Inquiry Before Buying
HIV RAPID TESTING MARKET - BY GEOGRAPHY
CHAPTER - 15

26. [email protected] |
❖
The China HIV Rapid Testing market is largely influenced by factors such as
increasing HIV prevalence, government initiatives to control the spread of
HIV/AIDS, growing awareness and increasing healthcare expenditure. The
increasing prevalence of HIV in China is driving the demand for HIV
rapid testing. According to the Chinese Center for Disease Control and
Prevention (CDC), the number of people living with HIV in China reached
1.25 million in 2019, and the number is still increasing. Also, According to
national estimates,an estimated 1.25 million people are livingwith HIV in
China, with almost 400 000 unaware of their status in 2021 The increasing
number of HIV cases is driving the demand for HIV rapid testing, which is
fast, easy, and accurate.
Moreover, the Chinese government has launched several initiatives to
control the spread of HIV/AIDS. In 2016, the Chinese government launched
the "13th Five-Year Plan for HIV/AIDS Prevention and Control", which
aimed to reduce the number of new HIV infections and AIDS-related
deaths, which in turn has led to an increase in HIV rapid testing
Furthermore, The awareness of HIV/AIDS has increased significantly in
China over the past few years. This has been driven by public health
campaigns, media coverage, anCdo peydruigchatt i©on2a0l 2p4
oIngdraumstsr.y ARs Ca result, more
people are getting tested for HIV, which is driving the demand for HIV rapid
testing.
❖
❖
❖
[phone] | Buy Now |
Inquiry Before Buying
100.00
80.00
60.00
40.00
20.00
0.00
Source: IndustryARC Analysis, Expert Insights
China: HIV Rapid Testing Market Revenue,
120.00
2022 - 2030 ($M)
Revenue in $M

27. Copyright ©2024 IndustryARC
| |[email protected] | [phone] Buy Now
Inquiry Before Buying
HIV RAPID TESTING MARKET COMPANY PROFILES
CHAPTER - 17

28. Copyright ©2024 IndustryARC
| |
Business Overview
[email protected] | [phone] Buy Now
Biosynex Group: Product Portfolio
Description
Biosynex Group : Developments
Inquiry Before Buying
Biosynex Group
Established Year
Headquarters
Employees
Revenue (2021-
2022)
Website
Description
2005
Alsace, France
<200
$403.5 Million
www.biosynex.com
Apr, 20, 2022
Sep, 23, 2022
Date
Mar, 15, 2023
NOTE :
Financials: Biosynex Group is a private company. Hence, financials are not disclosed.
Expansion
Expansion
Product Name
Biosynex Exacto Test
HIV
Approach
Acquisition
A rapid, visually read, in vitro immunoassay for
the qualitative detection of antibodies to HIV-
1 and HIV-2 in oral fluid specimens.
Description
Biosynex and Chembio diagnostics has
announced for definitive Acquisition Agreement.
Theradiag, a company specializing in vitro
diagnostics and Theranostics has announced that
Biosynex has filed a voluntary takeover bid for its
shares.
Biosynex has announced that it has acquired
PARAKITO which is operated by Hong Kong based
EVERGREEN LAND LTD.
Source: Company News and Press Releases

29. Copyright ©2024 IndustryARC
Thank You!
IndustryARC
[phone]/38
[email protected]
Page - 29
Web - www.industryarc.com|Mail – sales@indust